» Articles » PMID: 28116872

Recent Insights into Insulin-Like Growth Factor Binding Protein 2 Transcriptional Regulation

Overview
Specialty Endocrinology
Date 2017 Jan 25
PMID 28116872
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Insulin-like growth factor binding proteins (IGFBPs) are major regulators of insulin-like growth factor bioavailability and activity in metabolic signaling. Seven IGFBP family isoforms have been identified. Recent studies have shown that IGFBPs play a pivotal role in metabolic signaling and disease, including the pathogenesis of obesity, diabetes, and cancer. Although many studies have documented the various roles played by IGFBPs, transcriptional regulation of IGFBPs is not well understood. In this review, we focus on the regulatory mechanisms of IGFBP gene expression, and we summarize the findings of transcription factor activity in the IGFBP promoter region.

Citing Articles

Multi-miRNAs-Mediated Hepatic Lepr Axis Suppression: A Pparg-Dicer1 Pathway-Driven Mechanism in Spermatogenesis for the Intergenerational Transmission of Paternal Metabolic Syndrome.

Lin Y, Ni X, Zhu L, Lin Y, Peng C, Lei Z Adv Sci (Weinh). 2025; 12(9):e2410831.

PMID: 39792613 PMC: 11884570. DOI: 10.1002/advs.202410831.


Signaling pathways in liver cancer: pathogenesis and targeted therapy.

Xue Y, Ruan Y, Wang Y, Xiao P, Xu J Mol Biomed. 2024; 5(1):20.

PMID: 38816668 PMC: 11139849. DOI: 10.1186/s43556-024-00184-0.


The Role of Insulin-like Growth Factor (IGF) System in the Corneal Epithelium Homeostasis-From Limbal Epithelial Stem Cells to Therapeutic Applications.

Woronkowicz M, Roberts H, Skopinski P Biology (Basel). 2024; 13(3).

PMID: 38534414 PMC: 10968623. DOI: 10.3390/biology13030144.


Predictive potential of various plasma inflammation-, angiogenesis-, and extracellular matrix remodeling-associated mediators for intra-amniotic inflammation and/or microbial invasion of the amniotic cavity in preterm labor.

Joo E, Hong S, Park K, Kim H, Lee M, Shin S Arch Gynecol Obstet. 2024; 310(1):413-426.

PMID: 38329550 DOI: 10.1007/s00404-024-07378-5.


Receptor Tyrosine Kinase: Still an Interesting Target to Inhibit the Proliferation of Vascular Smooth Muscle Cells.

Xiong Y, Wang Y, Yang T, Luo Y, Xu S, Li L Am J Cardiovasc Drugs. 2023; 23(5):497-518.

PMID: 37524956 DOI: 10.1007/s40256-023-00596-3.


References
1.
Clemmons D, Snyder D, Busby Jr W . Variables controlling the secretion of insulin-like growth factor binding protein-2 in normal human subjects. J Clin Endocrinol Metab. 1991; 73(4):727-33. DOI: 10.1210/jcem-73-4-727. View

2.
Lynch G, Cuffe S, Plant D, Gregorevic P . IGF-I treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice. Neuromuscul Disord. 2001; 11(3):260-8. DOI: 10.1016/s0960-8966(00)00192-9. View

3.
Schoen T, Mazuruk K, Waldbillig R, Potts J, Beebe D, Chader G . Cloning and characterization of a chick embryo cDNA and gene for IGF-binding protein-2. J Mol Endocrinol. 1995; 15(1):49-59. DOI: 10.1677/jme.0.0150049. View

4.
Chua C, Liu Y, Granberg K, Hu L, Haapasalo H, Annala M . IGFBP2 potentiates nuclear EGFR-STAT3 signaling. Oncogene. 2015; 35(6):738-47. PMC: 4615268. DOI: 10.1038/onc.2015.131. View

5.
Levi J, Huynh F, Denroche H, Neumann U, Glavas M, Covey S . Hepatic leptin signalling and subdiaphragmatic vagal efferents are not required for leptin-induced increases of plasma IGF binding protein-2 (IGFBP-2) in ob/ob mice. Diabetologia. 2011; 55(3):752-62. DOI: 10.1007/s00125-011-2426-8. View